Viral And Non-Viral Vector Manufacturing Market Trends 2025-2034: Growth, Strategic Insights, and Opportunities Ahead
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has The Viral And Non-Viral Vector Manufacturing Market Size Shifted, And What Is the Outlook Through 2034?
The market size for manufacturing viral and non-viral vectors has shown a quick expansion lately. There is an expected rise from $8.67 billion in 2024 to $10.28 billion in 2025 indicating a compound annual growth rate (CAGR) of 18.5%. Factors supporting this growth in the historical phase include an increase in genetic disorders, advancements in biotechnology, escalated funding in gene therapy research, heightened consciousness of personalized medicine, and regulatory encouragement for gene therapy advancement.
The market size for manufacturing viral and non-viral vectors is set to experience remarkable growth in the forthcoming years. The market is projected to expand to $22.01 billion by 2029, at a compound annual growth rate (CAGR) of 21.0%. The surge during the forecast period can be credited to the escalating demand for gene therapies, the broadening scope in the treatment of rare diseases, an upswing in investments towards biomanufacturing infrastructure, and the increasing endorsement of precision medicine. In the forecast period, key market trends will include the emergence of more advanced viral vectors, augmented utilization of CRISPR or cas9 technology in vector production, emphasis on scalable and cost-efficient manufacturing procedures, a rising preference for non-viral vectors, and progress in cell and gene therapy manufacturing technologies.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12570&type=smp
What Are the Major Market Drivers Behind the Rising Adoption of Viral And Non-Viral Vector Manufacturing Market?
The growth of the viral and non-viral vector manufacturing markets is projected to be driven by the escalating occurrence of genetic disorders. These disorders are entirely or partially caused by variations from the normal DNA sequence. Therapeutic genes are delivered to target cells by viral vectors, replacing or supplementing the faulty genes responsible for genetic disorders. Non-viral vectors, on the other hand, are commonly employed in ex vivo gene therapy techniques, where cells are genetically altered outside the body and then reintroduced into the patient. For example, the International Diabetes Federation, a Belgian diabetes federation, reported in June 2022 that the global prevalence of diabetes had risen to 10.5%, with more than half (44.7%) of those affected still undiagnosed and about 783 million adults, or one in eight individuals, predicted to have diabetes by 2045. As a result, the upward trend in the occurrence of genetic disorders stimulates the expansion of the viral and non-viral vector manufacturing market.
Which Key Market Segments Comprise the Viral And Non-Viral Vector Manufacturing Market and Drive Its Revenue Growth?
The viral and non-viral vector manufacturingmarket covered in this report is segmented –
1) By Vector Type: Viral Vector; Non-Viral Vector
2) By Disease: Cancer; Genetic Disease; Infectious Disease; Cardiovascular Disease; Other Diseases
3) By Application: Gene Therapy; Vaccinology; Cell Therapy; Other Applications
Subsegments:
1) By Viral Vector: Adenoviral Vectors; Lentiviral Vectors; AAV (Adeno-Associated Virus) Vectors; Retroviral Vectors; Other Viral Vectors
2) By Non-Viral Vector: Plasmid DNA; Lipid-Based Vectors; Nanoparticles; Electroporation-Based Vectors; Other Non-Viral Vectors
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=12570&type=smp
Which Areas Are Leading Regions in the Viral And Non-Viral Vector Manufacturing Market Expansion Across the Globe?
North America was the largest region in the viral and non-viral vector manufacturing market in 2024. The regions covered in the viral and non-viral vector manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Are the Strategic Trends Steering theViral And Non-Viral Vector Manufacturing Market Direction?
Technological innovation is emerging as a significant trend in the viral and non-viral vector production markets, with key industry players creating advanced solutions to maintain their market standing. For instance, Merck KGaA, a German science and technology firm, unveiled the VirusExpress 293 Adeno-Associated Virus (AAV) Production Platform in August 2022. This company is one of the pioneers in offering a comprehensive viral vector manufacturing package, encompassing AAV, Lentiviral, CDMO, CTO, and process development. This groundbreaking platform assists biopharmaceutical companies in reducing development costs and time, while also speeding up the transition to clinical manufacture.
View the full report here:
How Is the Viral And Non-Viral Vector Manufacturing Market Conceptually Defined?
Viral and non-viral vector manufacturing refers to producing viral and non-viral vectors, tools that deliver genetic material into cells. Viral vectors treat human diseases and are used in anticancer and gene therapies. Non-viral vectors are utilized for a variety of gene therapy applications, particularly for the creation of vaccines and the treatment of cancer.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12570
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
